Fibryga

Product Specs	FIBRYGA
Manufacturer Name	Octapharma
Indications	FIBRYGA is indicated for the treatment of acute bleeding episodes in adults and adolescents with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia
Contraindications	Anaphylactic or severe reactions to FIBRYGA or its components.
Viral Safety Process	Solvent/detergent and nanofiltration
Product Half-Life	75.9 ± 23.8 hours
Manufacturing Method	Human-Derived Plasma
Storage Requirements/Shelf Life	Store at 2°C to 25°C (36°F to 77°F) for up to 30 months from date of manufacture. Do not freeze. Store in the original container to protect from light. After reconstitution, do not refrigerate or freeze. Use the reconstituted solution immediately or within 4 hours.
Nominal Vial Size & Diluent Volume	1 g/50 mL